Special Announcement - Now Screening for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for an FDA-approved stem cell clinical trial for knee arthritis. Our clinic is now screening patients for this trial. Contact us at 312-475-1893 for details. Click here to learn more.

It has been many years since I took personal time off to change offices and receive a “tune up” for my arthritic joint right hip. I am back. This past Wednesday, I completed three concentrated bone marrow procedures in my new settings under local anesthesia in our specially designed treatment room. Because the patients are participating in a Clinical Study, when combined with the elimination of the surgi-center dependency, the cost of Regenerative care for an arthritic joint is far less when compared to previous fee schedules. The same holds true for next Wednesday when the emphasis will be on Micro-fractured Fat following a mini-liposuction for those whose needs are best served by the latter methodology. Those patients who meet the micro-fractured adipose tissue inclusion criteria will also be entered into our Outcomes protocol and thus enjoy a cost reduction. Keeping in mind that my practice is evidence-based with treatment decisions made using scientific methodology and not an advertisement and a testimonial by a paid spokesperson; it requires an office assessment and review of images to enable me to make a definitive recommendation. We also use the full scope of Platelet Rich Plasma (PRP) alternatives and other Biologics when deemed appropriate.

For those who have stored adipose tissue from the first FDA-approved Stem Cell Clinical Trial, I am afraid we have to wait for a ruling on The FDA’s contesting of the California Appellate Court 2022 opinions. In the latter, Stem Cell culturing and usage was ruled part of the practice of medicine but then the FDA challenged the decision so we have to wait for the legal process to run its course. By the same token, for those interested in the second Personalized Stem Cell Clinical trial, the application is in progress; as of yesterday, PSC indicated a decision by the FDA should be forthcoming in 2023. Please understand that I share your frustration as my adipose tissue is waiting in the PSC deep freeze until the FDA to allows my arthritic knees to be addressed.

As I see it, the best option for a patient with symptomatic and functional limitations from an arthritic joint would be to call (312) 475-1893 and schedule an examination, review of images, and consultation. The ethos of my practice is informed consent. As of Thursday, March 16, 2023 patients will have a choice of locations including the 618 W Fulton Chicago office and the Glenview office, 2200 Waukegan Rd.

Pin It on Pinterest

Share This